Month: May 2020 (Page 13)

On:

When Waterloo Brewing started laying the groundwork to enter the cannabis-infused beverage market, it touted a potential beverage segment in Canada worth upwards of 1.5 billion Canadian dollars ($1.07 billion). Now, more than two years later, one of Canada’s most successful craft brewers is shelving the plans. What happened? “WhenContinue Reading

On:

A Montana group, rebuffed in its effort to collect digital signatures for a recreational marijuana legalization campaign, said Thursday it will begin collecting signatures in person while following strict public health protocols. New Approach Montana plans to start the signature drive May 9 and hopes to collect the necessary 25,468Continue Reading

On:

Two vacant Iowa medical marijuana dispensary licenses have attracted 18 pre-applications, or letters of intent. The dispensary licenses have been available since Have a Heart Compassionate Care, based in Washington state, closed its dispensaries in Council Bluffs and Davenport in March. Final applications are due June 8, and the identities of applicantsContinue Reading

On:

Nancy Whiteman, CEO of Boulder, Colorado-based infused product company Wana Brands, will join an Instagram Live Chat on Thursday afternoon with Marijuana Business Daily senior reporter John Schroyer. Whiteman will be taking questions during the session, which begins at 4:30 ET/1:30 PT. Despite the uncertainties caused by the COVID-19 pandemic, Whiteman believes theContinue Reading

On:

The Florida Supreme Court heard arguments via teleconference Wednesday on two issues that could significantly alter the state’s marijuana industry. One case is a longstanding issue of whether the vertically integrated structure of the Florida’s medical marijuana industry violates the state constitution. So far, lower courts have agreed with the assertionContinue Reading

On:

Approvals of medical cannabis prescriptions in Australia held steady as the country hunkered down for its battle with the COVID-19 pandemic, new data shows. The Therapeutic Goods Administration approved more than 7,300 Special Access Scheme Category B (SAS B) cumulative applications in March and April. That compares with approximately 6,700Continue Reading